Loading stock analysis…
Evidence Synthesis
Last synthesized: 11 Jul 2026, 07:12
Evidence Synthesis
NEOGEN has accelerated its 45.89% to a new high, up from 14.73% in the previous quarter.
The company's has also seen a significant acceleration, up from in the previous quarter.
Source observations behind the synthesis narrative.
| Metric | Value | Previous Value | Trend |
|---|---|---|---|
| GROSS_MARGIN | 45.89 % | 14.73 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 14.73 % | 3.34 | ▲ |
| REVENUE_GROWTH_YOY | 21.6 % | 375.9 | ▼ |
| EPS_ACTUAL | 3.89 INR | 1.28 | ▲ |
| EPS_SURPRISE_PERCENT | -0.341 % | -0.688 | ▲ |
| PRICE_CHANGE_PERCENT | 3.885 % | — | - |
| DAILY_VOLUME | 87,735 shares | 1,24,846 | ▼ |
| CLOSE_PRICE | 2,026.7 INR | 1,950.9 | ▲ |
| NEWS_SENTIMENT_SCORE | 0.67 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 4 count | 3 | ▲ |
| TARGET_PRICE_PREMIUM | -7.57 % | — | - |